Deoxymethylspergualin
Alternative Names: MeDSGLatest Information Update: 14 Nov 2003
At a glance
- Originator Nonindustrial source
- Class Antineoplastics; Guanidines; Small molecules
- Mechanism of Action Interleukin 2 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Transplant rejection
Most Recent Events
- 14 Nov 2003 Discontinued for Transplant rejection in Japan (unspecified route)
- 18 May 2001 No-Development-Reported for Transplant rejection in Japan (Unknown route)